About Inductive Bio
Inductive Bio is a Healthcare company based in New York (United States) founded in 2022 by Josh Haimson and Ben Birnbaum. Machine learning platform for drug discovery and development is provided. Inductive Bio has raised $29.41 million across 2 funding rounds from investors including Bessemer Venture Partners, Andreessen Horowitz and Lux Capital. Its chief executive, as recorded, is Josh Haimson. Inductive Bio offers products and services including Chemistry Design Software, ML Models, and Proprietary ADMET Data. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is Inductive Bio, Inc. Its competitors include Formation Bio, AbSci and BigHat; 3 of its 3 listed competitors have raised funding.
Company details
Inductive Bio was founded in 2022 in New York, United States, as a developer of machine learning-based platforms. Focus is placed on drug discovery and development within the biotechnology sector. Operations involve AI-driven tools to support pharmaceutical processes. The company is led by co-founder and CEO Josh Haimson, along with founder Ben Birnbaum. Services target efficiency in identifying potential drug candidates across various therapeutic areas.
- Headquarters New York, United States
- Founders Josh Haimson, Ben Birnbaum
- SectorsHealthcare
- Website inductive.bio
- Legal Name Inductive Bio, Inc.
- Total Equity Funding$29.41M (USD)
in 2 rounds
- Latest Funding Round$25.11M (USD), Series A
Mar 2025
- InvestorsBessemer Venture Partners
& 4 more
Products & Services of Inductive Bio
Inductive Bio offers a comprehensive portfolio of products and services, including Chemistry Design Software, ML Models, and Proprietary ADMET Data.
Intuitive tool for real-time ML predictions in compound design.
High-performing models for ADMET decision making in drug programs.
Curated datasets for mapping small-molecule ADMET drivers.
Funding Insights of Inductive Bio
Inductive Bio has successfully raised a total of $29.41M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $25.11 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $29.41M
- Total Rounds 2
- Last Round Series A — $25.11M
- First Round $4.3M
(Dec 2023)
- Investors Count 5
All 2 funding rounds of Inductive Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $25.11M | Series A | – | – | – |
| Dec 2023 | $4.3M | Seed | – | a16z, Lux Capital |
5 investors in total: 5 institutional.
Investors in Inductive Bio
Inductive Bio has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Bessemer Venture Partners, Andreessen Horowitz and Lux Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments in technology sectors are handled by Andreessen Horowitz. | a16z.com | |||
Seed and early-stage technology companies are funded by Lux Capital. | luxcapital.com | Menlo Park, United States | ||
| character.vc | ||||
Venture capital investments and support for entrepreneurs in technology and innovation sectors. | 1911 | bvp.com | Redwood City, United States | |
Venture capital-backed accelerator focused on healthcare and multiple sectors. | alleycorp.com | New York, United States |
Investor details for Inductive Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Inductive Bio
2 people are tracked at Inductive Bio (2 in leadership).
| Name | Role | Group |
|---|---|---|
Josh Haimson | Co-Founder & CEO | Leadership |
Ben Birnbaum | Founder | Leadership |
Complete people profiles for Inductive Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Inductive Bio
3 dated milestones of Inductive Bio across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Inductive Bio is founded.
- Funding First funding round of $4.3M.
- Funding Latest funding round, Series A, of $25.1M.
Competitors of Inductive Bio
Inductive Bio has 3 listed competitors in our database, 3 of them funded. They include Formation Bio, AbSci and BigHat.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| formation.bio | 2016 | New York, United States | $608.25M | AI-powered drug discovery platform for various diseases | ||
| absci.com | 2011 | Vancouver, United States | $227.56M | 256 | AI-based technology is used for recombinant protein production in therapeutics. | |
| bighatbio.com | 2019 | San Carlos, United States | $148.41M | Antibody therapies are developed through machine learning and synthetic biology. |
Detailed competitors of Inductive Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Inductive Bio
The website of Inductive Bio (inductive.bio) receives about 8.4K visits a month.
- Monthly visits8.4K
▼ 14.3% vs previous month
Websites whose visitors overlap most with Inductive Bio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pharmaceutical-tech.com | 100% | #1,417,513 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Inductive Bio (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Inductive Bio
Complete news archive for Inductive Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inductive Bio
Inductive Bio was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Inductive Bio is headquartered in New York, United States. It is registered at New York, New York, United States.
Josh Haimson is the CEO of Inductive Bio, as recorded in our data. They have also founded this company.
Inductive Bio is a funded company, having raised a total of $29.41M across 2 funding rounds to date. The company's 1st funding round was a Seed of $4.3M, raised on Dec 2023.
Inductive Bio was founded in 2022 in New York, United States, as a developer of machine learning-based platforms. Focus is placed on drug discovery and development within the biotechnology sector. Operations involve AI-driven tools to support pharmaceutical processes. The company is led by co-founder and CEO Josh Haimson, along with founder Ben Birnbaum. Services target efficiency in identifying potential drug candidates across various therapeutic areas.
Inductive Bio's top competitors include Formation Bio, BigHat and AbSci.
Inductive Bio offers Chemistry Design Software, ML Models, and Proprietary ADMET Data.
Inductive Bio has 5 investors. Key investors include Bessemer Venture Partners, Andreessen Horowitz, Lux Capital, Character, and AlleyCorp.
Inductive Bio operates through Inductive Bio, Inc..